A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD4.52
- USD4.57
- USD4.38
- USD5.10
- 34.60%
- 16M
- 1.01M
- 1.27M
- 855M
- 2.71
- 1.30%
Stock News
yesterday
Here's why Jim Cramer thinks JPMorgan could be the next non-tech stock to reach a $1 trillion valuation
CNBC
yesterday
What stocks may need to rise in ‘a market for only the most bright-eyed optimists’
MarketWatch
yesterday
Josh Harris says you likely won't see more sports assets going public as values soar
CNBC
yesterday
NHL embracing return to Olympics after 12-year absence
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
